Pulse Biosciences, Inc Common Stock (DE)

PLSENASDAQUSD
25.33 USD
1.61 (5.98%)AT CLOSE (11:59 AM EDT)
25.37
0.04 (0.14%)
POST MARKET (AS OF 07:19 PM EDT)
Post Market
AS OF 07:19 PM EDT
25.37
0.04 (0.14%)
🟢Market: OPEN
Open?$26.13
High?$26.64
Low?$24.85
Prev. Close?$26.94
Volume?315.3K
Avg. Volume?355.2K
VWAP?$25.55
Rel. Volume?0.89x
Bid / Ask
Bid?$21.29 × 100
Ask?$29.19 × 100
Spread?$7.90
Midpoint?$25.24
Valuation & Ratios
Market Cap?1.9B
Shares Out?69.2M
Float?18.2M
Float %?26.6%
P/E Ratio?N/A
P/B Ratio?28.12
EPS?-$1.08
Dividend?0.00%
Ex-Dividend?N/A

Pulse Biosciences, Inc Common Stock (DE) (PLSE) trades at $25.37 per share. Technicals currently rate "Buy" while our fundamental analysis reads "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.

Technical & fundamental data as of Jun 5, 2026.

News
Profile
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
Employees
116
Market Cap
1.7B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Listed
2016-05-18
Address
3957 POINT EDEN WAY
HAYWARD, CA 94545
Phone: 510-906-4600
Technical OutlookBuy
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bullish(+2/3)
Medium-Term (Wave)? Neutral(0/3)
Short-Term (Ripple)? Neutral(0/3)
MA Alignment?Golden Alignment
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
55
Short Sent.?
40
Piotroski F-Score?0/9Weak
Altman Z-Score?62.49Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?17.72%High
Short Interest?3.2M
Days to Cover?6.9
Free Float18.2M
Avg Daily Volume463.6K
Settlement Date2026-05-15
Financial Health
Current Ratio?7.26Strong
Quick Ratio?7.24Strong
Cash Ratio?6.97Strong
Debt/Equity?0.00Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score
50/100
P/E?
N/A
P/B?
Peers
100
S&P
3
28.12HIGH
P/S?
Peers
100
S&P
3
2,482.70HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-23.3CHEAP
EV/Sales?
Peers
100
S&P
3
2,391.73HIGH
Returns & Efficiency
ROE?
S&P
3
-112.5%WEAK
ROA?
S&P
3
-91.4%WEAK
Cash Flow & Enterprise
FCF?$-55499000
Enterprise Value?$1.8B
Fundamentals ratios updated end of day